Trial site
Istanbul
Istanbul, TürkiyeNot linked to an institution yet
The trials here
What the 2 trials at this site are about, from their registry records.
- Phase
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Samsung Bioepis Co., Ltd.2 trials
Running trials
Active, not recruiting
A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
NCT06348199· Phase 3· Samsung Bioepis Co., Ltd.· Source
Active, not recruiting
A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy
NCT06268613· Phase 1· Samsung Bioepis Co., Ltd.· Source
Report an error